Clinical Trials Logo

Capsule Opacification clinical trials

View clinical trials related to Capsule Opacification.

Filter by:

NCT ID: NCT00335439 Completed - Clinical trials for Macular Edema, Cystoid

Effect of Prophylactic Ketorolac on CME After Cataract Surgery

Start date: June 2006
Phase: N/A
Study type: Interventional

The study will evaluate the efficacy of prophylactic administration of the topical nonsteroidal anti-inflammatory drug (NSAID) ketorolac tromethamine 0.5% (Acular®) on cystoid macular edema (CME) in patients having undergone cataract surgery. CME is the most frequent cause of decreased vision after uncomplicated cataract surgery and can result in irreversible sight reduction. The investigation will involve a comparison arm and a treatment arm with both sets of patient populations being evaluated for CME with ophthalmologic examinations and optical coherence tomography (OCT) measurements. The objective is to elucidate the role of NSAID drops in preventing CME after cataract surgery.

NCT ID: NCT00312299 Completed - Cataract Clinical Trials

Posterior Capsule Opacification Study

Start date: April 2006
Phase: Phase 4
Study type: Interventional

First object is to compare square edge PMMA with round edge PMMA IOL where the materials are same. Next objective is to compare square edge PMMA IOL with Acrysof IOL where the materials are different

NCT ID: NCT00170729 Completed - Cataract Surgery Clinical Trials

A Study to Compare Ocular Safety and Tolerability of Eye Drops Containing Prednisolone Acetate in Patients With Intraocular Inflammation After Cataract Surgery

Start date: August 17, 2004
Phase: Phase 4
Study type: Interventional

The primary objective was to demonstrate that two days of treatment with 0.5% prednisolone acetate eye-drops after cataract surgery are superior to vehicle in reducing the flare in the anterior chamber of the operated eye.